A Plug-and-Play Platform for the Formation of Trifunctional Cysteine Bioconjugates that also Offers Control over Thiol Cleavability. (2021)
Attributed to:
Site-selective antibody modification by cysteine-to-lysine transfer (CLT)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.bioconjchem.1c00057
PubMed Identifier: 33710874
Publication URI: http://europepmc.org/abstract/MED/33710874
Type: Journal Article/Review
Volume: 32
Parent Publication: Bioconjugate chemistry
Issue: 4
ISSN: 1043-1802